Big Board

Content Ideas
Result Content Idea Research
Result Content Idea Research
1 Neighborhood-level armed violence may increase children's risk for MDD
2 Tobacco withdrawal symptoms before and after nicotine deprivation in veteran smokers with posttraumatic stress disorder and with major depressive disorder
3 Biogen and Sage Therapeutics Announce Global Collaboration to Develop and Commercialize Potential Breakthrough Therapies in Depression and Movement Disorders | More News | News Channels
4 Biogen bets on depression drug in $1.5 billion deal with Sage Therapeutics
5 Clinical Study Shows Hallucinogenic Magic Mushroom Compound Psilocybin Relieves Depression
6 Magic mushroom therapy found effective for treating depression
7 Three Key Factors Tied to Higher Suicide Risk in BPD
8 Deficiencies in Theory of Mind in patients with schizophrenia, bipolar disorder, and major depressive disorder: A systematic review of secondary literature.
9 Major Depressive Disorder (MDD) Market Study, Competitive Strategies, Key Manufacturers, New Project Investment and Forecast 2026
10 Axsome Therapeutics Reports Third Quarter 2020 Financial Results and Provides Business Update
11 These celebrity-approved donuts have become a hit quarantine treat
12 Then and Now: Addressing Comorbid PTSD and MDD
13 Neuronetics iTBS: Quick Electromagnetic Stimulation For Depression
14 Massachusetts’ Biogen bets on depression drug with $1.5bn Sage Therapeutics deal
15 Signs of Major Depression Subtypes: Introduction
16 Understanding Cognition in Patients With MDD
17 Adjunctive Brexpiprazole Enhances Calming, Engagement in MDD
18 Major vs. persistent depressive disorder: Understanding dysthymia
19 Pharmacogenetic Testing: Does it Improve Therapy in Patients With MDD?
20 TMS offers similar benefit for MDD patients with and without comorbid PTSD
21 Global Major Depressive Disorder (MDD) Epidemiology Forecasts to 2028
22 Loss of Interest, Reduced Activity Indicates Need for Aripiprazole in MDD
23 Major Depressive Disorder May Increase Risk of Dementia
24 Higher Levels of Inflammatory Markers in Patients With MDD and Suicide Risk
25 Novel Antagonist Shows Potential for MDD in Phase 2 Study
26 Global Major Depressive Disorder (MDD) Market Insights, 2017-2028
27 Sociodemographic and Psychosocial Factors Predictive of Occurrence of MDD
28 Escitalopram combined with aripiprazole improves interest-activity reduction in MDD
29 Researchers report outcome predictors of repetitive transcranial magnetic stimulation for MDD
30 IV Ketamine for Adults With MDD or Bipolar Disorder: Safety and Tolerability
31 Suicidal Ideation May Moderate Frontal Alpha Asymmetry in MDD
32 Higher BMI, Being Obese/Overweight Linked to Ketamine Response in MDD
33 Researchers find replicable neuroimaging features for MDD
34 Replicating Neuroimaging Abnormalities in Major Depression
35 Youth With Social Anxiety, Exposure to Maternal MDD Have Higher Depression Risk
36 Mukula redefines qualifications as Amuriat buys a roadside chapatti
37 Nexstim Secures Business Finland Funding for the Development of Accelerated iTBS Protocols
38 Integrating Psychotherapy and Psychopharmacology in the Treatment of Major Depressive Disorder
39 Study Author Q&A: Alterations of the HPA Axis in Major Depressive Disorder
40 Pharmacogenetic Testing in Patients With MDD Linked to Shorter Hospital Stays
41 Vortioxetine may reduce MDD-related cognitive impairment
42 Spravato Approved for MDD With Acute Suicidal Ideation or Behavior
43 Identifying individual response factors to antidepressants may help tailor MDD treatment
44 University TMS Clinic Now Offering FDA-Cleared Helmet to Treat Major Depressive Disorder (MDD) and Obsessive-Compulsive Disorder (OCD)
45 Comorbid Depression Adversely Affects ART Adherence, Quality of Life
46 Sage Therapeutics Announces Positive Interim, Topline Zuranolone Safety and Tolerability Data from Open-Label SHORELINE Study in Patients with MDD
47 Emotional Reactivity, Explicit Emotional Memory Biases Not Present in MDD During Euthymia
48 Acadia pulls plug on pimavanserin for adjunctive MDD
49 Axsome Therapeutics Announces Further Progress in AXS-05 Depression Clinical Program
50 Major Depressive Disorder Raises Risk of Developing Autoimmune Skin Disease
51 Incremental Healthcare Costs for Persons With Treatment-resistant Depression in Managed Care Organizations
52 Study Finds Improved MDD Outcomes With Pharmacogenomic Test
53 Dr. Vladimir Maletic on Diet and Nutrition in Patients With MDD During the Pandemic
54 Amid COVID-19, Dr. Rakesh Jain Shares Learnings From 33 Years of Treating MDD
55 Symptoms of MDD May Actually Indicate Another Psychiatric Disorder
56 Add-on Pimavanserin Improves Insomnia, Sleepiness in MDD Study
57 Minerva MDD Treatment Fails Mid-Stage Trial, Company Has No Further Development Plans
58 Major Depressive Disorder: Disabling and Dangerous
59 Major Depressive Disorder and Burnout Syndrome May Predict Impaired Sleep Quality
60 MDD, noncombat trauma associated with suicide ideation among deployed soldiers
61 Sage's MDD Treatment Fails to Distinguish Itself from Placebo in Late-Stage Trial
62 Factors Correlated With Suicidal Ideation in Major Depressive Disorder
63 Anti-Inflammatory Treatments for MDD: Update and Expert Interview
64 Major Depressive Disorder: Symptoms, Causes, and Treatment
65 Pimavanserin Effective for Depression in Parkinson Disease, Major Depressive Disorder
66 IL-6 Receptor Serum Levels Can Act as a Biomarker for Treatment Resistant MDD
67 Neuronetics® Receives FDA Clearance for Three-Minute TouchStar™ Treatment Protocol
68 High Levels of Inflammation and Blood Glucose May Contribute to Anhedonia in MDD
69 Borderline Personality Disorder With Depression Raises Risk of Suicide Attempts in Mood Disorder Patients
70 Yoga Improves Symptoms in Study Participants With MDD
71 Michigan Advanced Psychiatry Opens New Facility To Offer Deep Transcranial Magnetic Stimulation (Deep TMS) for Patients With Major Depressive Disorder (MDD) and Obsessive-Compulsive Disorder (OCD)
72 ACADIA Pharmaceuticals Announces Top-line Results from the Phase 3 CLARITY Study Evaluating Pimavanserin for the Adjunctive Treatment of Major Depressive Disorder
73 Global Osteotome Market (2020-2026) | Latest COVID19 Impact Analysis | Know About Brand Players: SHINVA, Jinfeng Kangda, Dragonbio, MDD, YONGHUA, Shanghai Medical Instruments (Group) Ltd., Corp, etc.
74 Global Multimedia Desks Market 2020 Business Growth – Gallotti_Radice, TEAM 7, Versa Products, .mdd
75 Patients with MDD and suicide ideation/attempt experience significant health care costs
76 Ultradian Sleep Cycles Correlate With REM Alterations in Major Depression
77 Patients With Major Depressive Disorder, Social Phobia More Often Experience Embarrassing Social Interactions
78 Solace Behavioral Health Clinic Hosts Grand Opening to Introduce Newly Offered FDA-Cleared Helmet to Treat Major Depressive Disorder (MDD) and Obsessive-Compulsive Disorder (OCD)
79 Esketamine May Reduce Depressive Symptoms, But Not Suicide Severity
80 ACADIA Pharmaceuticals to Combine CLARITY-2 and CLARITY-3 Phase 3 Studies Evaluating Pimavanserin for the Adjunctive Treatment of Major Depressive Disorder
81 Experiential avoidance a predictor for MDD, GAD in older adolescents
82 Despite Antidepressants, Suicidal Ideation Affects 1 in 5 People With MDD
83 Moods During Depressive Episodes Differ in Bipolar and Major Depressive Disorders
84 Subthreshold Depression in Older Adults: Overview and Expert Interview
85 Axsome Therapeutics Completes Successful FDA Pre-NDA Meeting for AXS-05 for the Treatment of Major Depressive Disorder
86 Psilocybin Receives Breakthrough Therapy Designation for MDD
87 Pimavanserin Effective Against MDD in Antidepressant Nonresponders
88 Depression Worse After Treatment in Few With MDD
89 MDD: Closing in on the Right Drug at the Right Dose
90 What is Major Depressive Disorder?
91 US FDA Opens Door For J&J's Spravato To Another MDD Population
92 Hospitalization for MDD Costly, Associated With High Readmission Rates
93 West Yavapai Guidance Clinic Hosts Open House to Introduce Newly Offered FDA-Cleared Helmet to Treat Major Depressive Disorder (MDD) and Obsessive-Compulsive Disorder (OCD)
94 Clinical challenges in MDD patients with comorbid disorders
95 Study Summary: Effect of Comorbid MDD on HIV Disease Profression
96 Managing Major Depressive Disorder (MDD)
97 Economic Burden Among Patients With Major Depressive Disorder: An Analysis of Healthcare Resource Use, Work Productivity, and Direct and Indirect Costs by Depression Severity
98 Rocker Chair Market, 2020-2027: Top Companies, Cliff Young, Ambiance Italia, MDD, Vitra, ALIAS, CAPDELL, Calligaris, Bross Italia, Blå Station, BONALDO
99 Hoarding, Dysthymia, and Depression: A Tiring Trio
100 Therapeutic Response in Two Models of Brief Psychotherapy to Treat MDD